Unmet Need in Essential Thrombocythemia and Polycythemia Vera

被引：3
|
作者：
Kishtagari, Ashwin [1 ]
Gerds, Aaron T. [1 ]
机构：
[1] Cleveland Clin, Leukemia & Myeloid Disorders Program, Taussig Canc Inst, 9500 Euclid Ave,CA60, Cleveland, OH 44120 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 02期
关键词：
Myeloproliferative neoplasms; MPN; ET; PV; Bomedemstat; IFN-alpha; Idasanutlin; Givinostat;
D O I：
10.1016/j.hoc.2021.01.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Consensus guidelines have helped to standardize the care of patients with essential thrombocythemia and polycythemia vera, focusing on reducing the risk of thrombosis, mitigating symptoms, and avoiding therapies that may accelerate disease progression. However, many unmet needs still exist ranging from the roll of antiplatelet therapy in ET to medications that reduce disease progression. Retrospective studies suggest an improvement in myelofibrosis-free survival for treatment with interferons; new agents are looking to also enact disease modification. © 2021 Elsevier Inc.
引用
收藏
页码：295 / 303
页数：9
相关论文
共 50 条
  • [1] Essential thrombocythemia and polycythemia vera
    Griesshammer, Martin
    Kvasnicka, Hans M. M.
    Koschmieder, Steffen
    ONKOLOGIE, 2023, 29 (04): : 296 - 304
  • [2] Essential thrombocythemia and polycythemia vera
    Mammen, EF
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (03): : 169 - 170
  • [3] Prevalence of polycythemia vera and essential thrombocythemia
    Ma, Xiaomei
    Gary, K.
    Vanasse, J.
    Selinger, H. Andrew
    Wang, Yun
    Cartmel, Brenda
    BLOOD, 2007, 110 (11) : 240B - 240B
  • [4] Essential thrombocythemia/polycythemia vera and pregnancy: The need for an observational study in Europe
    Griesshammer, Martin
    Struve, Sabine
    Harrison, Claire M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (04): : 422 - 429
  • [5] Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?
    Sankar, Kamya
    Stein, Brady L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (12): : 1539 - 1545
  • [6] Eryptosis in polycythemia vera and essential thrombocythemia
    Kopka, Pawel
    Blizniewska, Katarzyna
    Sicinska, Paulina
    Duchnowicz, Piotr
    Bukowska, Bozena
    Trelinski, Jacek
    Chojnowski, Krzysztof
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2020, 74 : 69 - 76
  • [7] Prevalence of polycythemia vera and essential thrombocythemia
    Ma, Xiaomei
    Vanasse, Gary
    Cartmel, Brenda
    Wang, Yun
    Selinger, H. Andrew
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (05) : 359 - 362
  • [8] Polycythemia vera and essential thrombocythemia: algorithmic approach
    Vannucchi, Alessandro M.
    Guglielmelli, Paola
    Tefferi, Ayalew
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (02) : 112 - 119
  • [9] \ Erythromelalgia in patients with essential thrombocythemia and polycythemia vera
    Hou, Jennifer L.
    Onajin, Oluwakemi
    Gangat, Naseema
    Davis, Mark D. P.
    Wolanskyj, Alexandra P.
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 715 - 717
  • [10] Updates in the management of polycythemia vera and essential thrombocythemia
    Bose, Prithvirai
    Verstovsek, Srdan
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
12345